VP Medical Affairs

The Publication
Paradox

3 manuscripts delayed. 1 blocked for 98 days. 250+ cumulative impact factor stuck in your pipeline. Can you show leadership exactly where the bottlenecks are?

Publication Pipeline Status

From planning to published — track every manuscript through the pipeline.

Manuscript
Planning
Writing
Internal Review
Submission
Peer Review
Revision
Accepted
Published
Phase 3 Primary Endpoint ...
HighIF: 91.2
45d
Real-World Effectiveness ...
HighIF: 41.3
28d
Subgroup Analysis: Elderl...
MediumIF: 45.3
62d
Treatment Guidelines Upda...
High
14d
Mechanism of Action Revie...
MediumIF: 78.2
35d
Patient-Reported Outcomes
LowIF: 4.1
21d
Long-term Safety Analysis
HighIF: 32.9
BLOCKEDd
Case Series: Rare Adverse...
LowIF: 0.4
0d

Stage Distribution

1
Planning
1
Writing
1
Internal Review
1 delayed
1
Submission
1
Peer Review
1 delayed
1
Revision
1 delayed
0
Accepted
1
Published
6
Manuscripts In Progress
3
Delayed or At Risk
43d
Avg Days in Current Stage
293
Impact Factor in Pipeline

High-Priority Publications at Risk

Phase 3 Primary Endpoint Analysis
NEJM • IF: 91.2
DELAYED45 days in Peer Review
Long-term Safety Analysis
Annals of Oncology • IF: 32.9
BLOCKED98 days in Blocked

Publication Pipeline Health

4
On Track
3
Delayed / At Risk
1
Blocked

By Publication Type

4
Original Research
1
Review
1
Case Study
1
Guidelines
1
Real-World Evidence

From Publication Chaos to Pipeline Clarity

Without SlideStrike

  • Publications tracked in scattered spreadsheets
  • No visibility into bottleneck stages
  • High-priority manuscripts slip through cracks
  • Impact factor value not quantified
  • Leadership sees activity, not outcomes

With SlideStrike

  • Visual Gantt chart of entire pipeline
  • Stage-by-stage bottleneck identification
  • Priority-filtered dashboard views
  • Impact factor at risk calculations
  • Executive-ready publication reports

SlideStrike for Publication Excellence

Turn publication data into strategic intelligence

Pipeline Gantt
Visual stage tracking
Bottleneck Alerts
Stage delay warnings
Priority Scoring
Strategic importance ranking
Impact Analysis
IF value at risk
Time-in-Stage
Cycle time analytics
Type Distribution
Portfolio balance view

Publication Management Questions

QWhat is a publication paradox?

The publication paradox occurs when medical affairs teams have data ready for publication but publications remain stuck in pipeline limbo—delayed reviews, blocked submissions, or stalled peer reviews—while competitors publish first.

QWhy do pharma publications get delayed?

Common causes include slow internal medical-legal review (avg 45+ days), KOL author delays, journal desk rejections, and competing priorities. Each delay risks being scooped by competitors.

QWhat is impact factor and why does it matter?

Impact factor measures journal prestige and citation frequency. High-impact publications (IF >10) drive treatment adoption, guideline inclusion, and KOL engagement more effectively than low-impact journals.

QHow long should a publication take?

Target timelines vary: Original research 12-18 months, Reviews 6-9 months, Case studies 3-6 months. Exceeding these indicates pipeline problems requiring intervention.

QHow does SlideStrike track publication pipelines?

SlideStrike visualizes your entire publication pipeline as a Gantt chart, highlights blocked and delayed manuscripts, tracks time-in-stage, and calculates impact factor at risk for executive reporting.

Unstick Your Publication Pipeline

Stop losing impact factor to bottlenecks. See exactly where your manuscripts are stuck.

Track Your Publications